These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36234948)

  • 1. Cheminformatics Modeling of Gene Silencing for Both Natural and Chemically Modified siRNAs.
    Dong X; Zheng W
    Molecules; 2022 Sep; 27(19):. PubMed ID: 36234948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cheminformatics Approach to Gene Silencing: Z Descriptors of Nucleotides and SVM Regression Afford Predictive Models for siRNA Potency.
    Ebalunode JO; Zheng W
    Mol Inform; 2010 Dec; 29(12):871-81. PubMed ID: 27464351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modified siRNA structure with a single nucleotide bulge overcomes conventional siRNA-mediated off-target silencing.
    Dua P; Yoo JW; Kim S; Lee DK
    Mol Ther; 2011 Sep; 19(9):1676-87. PubMed ID: 21673662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Informatics approach to the rational design of siRNA libraries.
    Ebalunode JO; Jagun C; Zheng W
    Methods Mol Biol; 2011; 672():341-58. PubMed ID: 20838976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Competition for RISC binding predicts in vitro potency of siRNA.
    Koller E; Propp S; Murray H; Lima W; Bhat B; Prakash TP; Allerson CR; Swayze EE; Marcusson EG; Dean NM
    Nucleic Acids Res; 2006; 34(16):4467-76. PubMed ID: 16945958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Designing of highly effective complementary and mismatch siRNAs for silencing a gene.
    Ahmed F; Raghava GP
    PLoS One; 2011; 6(8):e23443. PubMed ID: 21853133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical modification of siRNA.
    Chernolovskaya EL; Zenkova MA
    Curr Opin Mol Ther; 2010 Apr; 12(2):158-67. PubMed ID: 20373259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzymatically produced pools of canonical and Dicer-substrate siRNA molecules display comparable gene silencing and antiviral activities against herpes simplex virus.
    Romanovskaya A; Paavilainen H; Nygårdas M; Bamford DH; Hukkanen V; Poranen MM
    PLoS One; 2012; 7(11):e51019. PubMed ID: 23226452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of bcr-abl mRNA by chemically modified siRNA.
    Murao S; Diala I; Fujii M
    Nucleic Acids Symp Ser (Oxf); 2008; (52):499-500. PubMed ID: 18776472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DEQOR: a web-based tool for the design and quality control of siRNAs.
    Henschel A; Buchholz F; Habermann B
    Nucleic Acids Res; 2004 Jul; 32(Web Server issue):W113-20. PubMed ID: 15215362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.
    Aigner A
    J Biotechnol; 2006 Jun; 124(1):12-25. PubMed ID: 16413079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The siRNA sequence and guide strand overhangs are determinants of in vivo duration of silencing.
    Strapps WR; Pickering V; Muiru GT; Rice J; Orsborn S; Polisky BA; Sachs A; Bartz SR
    Nucleic Acids Res; 2010 Aug; 38(14):4788-97. PubMed ID: 20360048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The design, preparation, and evaluation of asymmetric small interfering RNA for specific gene silencing in mammalian cells.
    Chang C; Hong SW; Dua P; Kim S; Lee DK
    Methods Mol Biol; 2013; 942():135-52. PubMed ID: 23027049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional features defining the efficacy of cholesterol-conjugated, self-deliverable, chemically modified siRNAs.
    Shmushkovich T; Monopoli KR; Homsy D; Leyfer D; Betancur-Boissel M; Khvorova A; Wolfson AD
    Nucleic Acids Res; 2018 Nov; 46(20):10905-10916. PubMed ID: 30169779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. siDirect 2.0: updated software for designing functional siRNA with reduced seed-dependent off-target effect.
    Naito Y; Yoshimura J; Morishita S; Ui-Tei K
    BMC Bioinformatics; 2009 Nov; 10():392. PubMed ID: 19948054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide identification of endogenous RNA-directed DNA methylation loci associated with abundant 21-nucleotide siRNAs in Arabidopsis.
    Zhao JH; Fang YY; Duan CG; Fang RX; Ding SW; Guo HS
    Sci Rep; 2016 Oct; 6():36247. PubMed ID: 27786269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing activity of 2'-O-methyl modified anti-MDR1 siRNAs with mismatches in the central part of the duplexes.
    Petrova NS; Meschaninova MI; Venyaminova AG; Zenkova MA; Vlassov VV; Chernolovskaya EL
    FEBS Lett; 2011 Jul; 585(14):2352-6. PubMed ID: 21704032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent progress in chemically modified siRNAs.
    Gaglione M; Messere A
    Mini Rev Med Chem; 2010 Jun; 10(7):578-95. PubMed ID: 20500149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SMEpred workbench: A web server for predicting efficacy of chemicallymodified siRNAs.
    Dar SA; Gupta AK; Thakur A; Kumar M
    RNA Biol; 2016 Nov; 13(11):1144-1151. PubMed ID: 27603513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Competition potency of siRNA is specified by the 5'-half sequence of the guide strand.
    Yoo JW; Kim S; Lee DK
    Biochem Biophys Res Commun; 2008 Feb; 367(1):78-83. PubMed ID: 18164261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.